Lexicon Pharmaceuticals
LXRX
LXRX
101 hedge funds and large institutions have $251M invested in Lexicon Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 33 increasing their positions, 39 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 39
48% less capital invested
Capital invested by funds: $479M → $251M (-$227M)
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
Holders
101
Holding in Top 10
1
Calls
$169K
Puts
$65K
Top Buyers
| 1 | +$878K | |
| 2 | +$876K | |
| 3 | +$420K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$416K |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$413K |
Top Sellers
| 1 | -$3.14M | |
| 2 | -$789K | |
| 3 | -$788K | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$771K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$654K |